Small dense LDL is more susceptible to glycation than more buoyant LDL in type 2 diabetes

Clinical Science

Volumn 124, Issue 5, 2013, Pages 343-349

  Younis, Nahla N ^a,b   Soran, Handrean ^a   Pemberton, Philip ^c   Charlton Menys, Valentine ^a   Elseweidy, Mohamed M ^b   Durrington, Paul N ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Zagazig University   (Egypt)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Glycated low density lipoprotein; Small dense low density lipoprotein; Statin; Type 2 diabetes mellitus

Indexed keywords

AMINO ACID; APOLIPOPROTEIN A; APOLIPOPROTEIN B; ATORVASTATIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SIMVASTATIN; SMALL DENSE LOW DENSITY LIPOPROTEIN; SULFONYLUREA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIABETIC PATIENT; DIET RESTRICTION; DOSE RESPONSE; ELECTROPHORETIC MOBILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

APOLIPOPROTEINS B; ATHEROSCLEROSIS; BLOOD GLUCOSE; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; GLYCOSYLATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE;

EID: 84871370372     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20120304     Document Type: Article

References (42)

1. Kearney, P. M., Blackwell, L., Collins, R., Keech, A., Simes, J., Peto, R., Armitage, J. and Baigent, C. (2008) Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in randomised trials of statins: a meta-analysis. Lancet 371, 117-125
2. Austin, M. A., Breslow, J. L., Hennekens, C. H., Buring, J. E., Willett, W. C. and Krauss, R. M. (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA, J. Am. Med. Assoc. 260, 1917-1921
3. Lamarche, B., Tchernof, A., Moorjani, S., Cantin, B., Dagenais, G. R., Lupien, P. J. and Despres, J. P. (1997) Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95, 69-75
4. Inukai, T., Yamamoto, R., Suetsugu, M., Matsumoto, S., Wakabayashi, S., Inukai, Y., Matsutomo, R., Takebayashi, K. and Aso, Y. (2005) Small low-density lipoprotein and small low-density lipoprotein/total low-density lipoprotein are closely associated with intima-media thickness of the carotid artery in Type 2 diabetic patients. J. Diabetes Complications 19, 269-275
5. Chait, A., Brazg, R. L., Tribble, D. L. and Krauss, R. M. (1993) Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am. J. Med. 94, 350-356
6. Liu, M. L., Ylitalo, K., Vakkilainen, J., Nuotio, I., Valkonen, M., Lahdenpera, S., Viikari, J. and Taskinen, M. R. (2002) Susceptibility of LDL to oxidation in vitro and antioxidant capacity in familial combined hyperlipidemia: comparison of patients with different lipid phenotypes. Ann. Med. 34, 48-54
7. Steinberg, D. and Witztum, J. L. (2010) Oxidized low-density lipoprotein and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30, 2311-2316
8. Steinbrecher, U. P. (1987) Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262, 3603-3608
9. Matsuura, E., Hughes, G. R. and Khamashta, M. A. (2008) Oxidation of LDL and its clinical implication. Autoimmun. Rev. 7, 558-566
10. Itabe, H. and Takano, T. (2000) Oxidized low density lipoprotein: the occurrence and metabolism in circulation and in foam cells. J. Atheroscler. Thromb. 7, 123-131
11. Younis, N., Sharma, R., Soran, H., Charlton-Menys, V., Elseweidy, M. and Durrington, P. N. (2008) Glycation as an atherogenic modification of LDL. Curr. Opin. Lipidol. 19, 378-384
12. Holvoet, P., Mertens, A., Verhamme, P., Bogaerts, K., Beyens, G., Verhaeghe, R., Collen, D., Muls, E. and Van de Werf, F. (2001) Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 21, 844-848
13. Holvoet, P., Macy, E., Landeloos, M., Jones, D., Jenny, N. S., Van de Werf, F. and Tracy, R. P. (2006) Analytical performance and diagnostic accuracy of immunometric assays for the measurement of circulating oxidized LDL. Clin. Chem. 52, 760-764
14. Tames, F. J., Mackness, M. I., Arrol, S., Laing, I. and Durrington, P. N. (1992) Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects. Atherosclerosis 93, 237-244
15. Younis, N. N., Soran, H., Sharma, R., Charlton-Menys, V., Greenstein, A., Elseweidy, M. M. and Durrington, P. N. (2010) Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes. Diabetes Vasc. Dis. Res. 7, 289-295
16. Moro, E., Alessandrini, P., Zambon, C., Pianetti, S., Pais, M., Cazzolato, G. and Bon, G. B. (1999) Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition? Diabetic Med. 16, 663-669
17. Younis, N., Charlton-Menys, V., Sharma, R., Soran, H. and Durrington, P. N. (2009) Glycation of LDL in non-diabetic people: small dense LDL is preferentially glycated both in vivo and in vitro. Atherosclerosis 202, 162-168
18. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation, World Health Organization, Geneva
19. Jack, C. M., Sheridan, B., Kennedy, L. and Stout, R. W. (1988) Non-enzymatic glycosylation of low-density lipoprotein. Results of an affinity chromatography method. Diabetologia 31, 126-127
20. Gambino, R., Uberti, B., Alemanno, N., Pisu, E., Pagano, G. and Cassader, M. (2004) In vivo oxidizability of LDL in type 2 diabetic patients in good and poor glycemic control. Atherosclerosis 173, 103-107
21. Habeeb, A. F. (1966) Determination of free amino groups in proteins by trinitrobenzenesulfonic acid. Anal. Biochem. 14, 328-336
22. el-Saadani, M., Esterbauer, H., el-Sayed, M., Goher, M., Nassar, A. Y. and Jurgens, G. (1989) A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30, 627-630
23. Menys, V. C., Liu, Y., Mackness, M. I., Caslake, M. J., Kwok, S. and Durrington, P. N. (2003) Measurement of plasma smalldense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B. Clin. Chim. Acta 334, 95-106
24. Brown, R. E., Jarvis, K. L. and Hyland, K. J. (1989) Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal. Biochem. 180, 136-139
25. Brown, B. E., Dean, R. T. and Davies, M. J. (2005) Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells. Diabetologia 48, 361-369
26. Steinbrecher, U. P. and Witztum, J. L. (1984) Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism. Diabetes 33, 130-134
27. Packard, C. J. (2003) Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem. Soc. Trans. 31, 1066-1069
28. Caslake, M. J., Stewart, G., Day, S. P., Daly, E., McTaggart, F., Chapman, M. J., Durrington, P., Laggner, P., Mackness, M., Pears, J. and Packard, C. J. (2003) Phenotype-dependent and -independent actions of rosuvastatin on atherogenic lipoprotein subfractions in hyperlipidaemia. Atherosclerosis 171, 245-253
29. Karalis, D. G., Ishisaka, D. Y., Luo, D., Ntanios, F. and Wun, C. C. (2007) Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia. Am. J. Cardiol. 100, 445-449
30. Nozue, T., Michishita, I., Ito, Y. and Hirano, T. (2008) Effects of statin on small dense low-density lipoprotein cholesterol and remnant-like particle cholesterol in heterozygous familial hypercholesterolemia. J. Atheroscler. Thromb. 15, 146-153
31. Dyer, D. G., Blackledge, J. A., Thorpe, S. R. and Baynes, J. W. (1991) Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo. J. Biol. Chem. 266, 11654-11660
32. Mackness, M. I., Abbott, C., Arrol, S. and Durrington, P. N. (1993) The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation. Biochem. J. 294, 829-834
33. Vekic, J., Kotur-Stevuljevic, J., Jelic-Ivanovic, Z., Spasic, S., Spasojevic-Kalimanovska, V., Topic, A., Zeljkovic, A., Stefanovic, A. and Zunic, G. (2007) Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects. Eur. J. Clin. Invest. 37, 715-723
34. Soran, H., Younis, N. N., Charlton-Menys, V. and Durrington, P. (2009) Variation in paraoxonase-1 activity and atherosclerosis. Curr. Opin. Lipidol. 20, 265-274
35. Njajou, O. T., Kanaya, A. M., Holvoet, P., Connelly, S., Strotmeyer, E. S., Harris, T. B., Cummings, S. R. and Hsueh, W. C. (2009) Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Diabetes Metab. Res. Rev. 25, 733-739
36. Nakhjavani, M., Khalilzadeh, O., Khajeali, L., Esteghamati, A., Morteza, A., Jamali, A. and Dadkhahipour, S. (2010) Serum oxidized-LDL is associated with diabetes duration independent of maintaining optimized levels of LDL-cholesterol. Lipids 45, 321-327
37. Tsimikas, S., Witztum, J. L., Miller, E. R., Sasiela, W. J., Szarek, M., Olsson, A. G. and Schwartz, G. G. (2004) High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. Circulation 110, 1406-1412
38. Brown, B. E., Rashid, I., van Reyk, D. M. and Davies, M. J. (2007) Glycation of low-density lipoprotein results in the time-dependent accumulation of cholesteryl esters and apolipoprotein B-100 protein in primary human monocyte-derived macrophages. FEBS J. 274, 1530-1541
39. Sobal, G., Menzel, J. and Sinzinger, H. (2000) Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study. Prostaglandins Leukot. Essent. Fatty Acids 63, 177-186
40. Han, J., Nicholson, A. C., Zhou, X., Feng, J., Gotto, Jr, A. M. and Hajjar, D. P. (2001) Oxidized low density lipoprotein decreases macrophage expression of scavenger receptor B-I. J. Biol. Chem. 276, 16567-16572
41. Krauss, R. M. (2004) Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27, 1496-1504
42. Zinellu, A., Zinellu, E., Sotgia, S., Formato, M., Cherchi, G. M., Deiana, L. and Carru, C. (2006) Factors affecting S-homocysteinylation of LDL apoprotein B. Clin. Chem. 52, 2054-2059